Basic Information
Basic information for SNHG14-325-14aa-4
Peptide Name SNHG14-325-14aa-4
Genome Position chr15:25119445-25119486[+]
Species Human
Peptide Sequence MIFFQKFKAYLNNI
Peptide Length 14
Unique No (SNHG14-210-14aa-3,SNHG14-223-14aa,SNHG14-224-14aa-7,SNHG14-227-14aa-1,SNHG14-230-14aa-5,SNHG14-231-14aa-4,SNHG14-232-14aa-4,SNHG14-235-14aa-5,SNHG14-236-14aa-2,SNHG14-238-14aa,SNHG14-239-14aa-1,SNHG14-242-14aa-1,SNHG14-248-14aa-5,SNHG14-249-14aa-4,SNHG14-251-14aa-2,SNHG14-254-14aa-3,SNHG14-255-14aa-2,SNHG14-257-14aa-3,SNHG14-263-14aa,SNHG14-268-14aa-3,SNHG14-269-14aa-7,SNHG14-270-14aa-3,SNHG14-272-14aa-5,SNHG14-274-14aa-1,SNHG14-275-14aa-2,SNHG14-276-14aa-3,SNHG14-277-14aa-2,SNHG14-278-14aa-1,SNHG14-279-14aa-1,SNHG14-280-14aa-4,SNHG14-281-14aa-2,SNHG14-282-14aa-6,SNHG14-283-14aa-2,SNHG14-287-14aa-2,SNHG14-288-14aa-3,SNHG14-289-14aa,SNHG14-293-14aa-1,SNHG14-297-14aa,SNHG14-298-14aa-3,SNHG14-300-14aa-1,SNHG14-301-14aa-2,SNHG14-302-14aa-1,SNHG14-303-14aa,SNHG14-304-14aa-1,SNHG14-309-14aa-5,SNHG14-311-14aa-4,SNHG14-312-14aa-2,SNHG14-313-14aa-4,SNHG14-314-14aa-1,SNHG14-315-14aa,SNHG14-318-14aa-5,SNHG14-319-14aa-2,SNHG14-321-14aa,SNHG14-322-14aa-2,SNHG14-323-14aa-4,SNHG14-324-14aa-2,SNHG14-330-14aa-1,SNHG14-332-14aa-3,SNHG14-333-14aa-3,SNHG14-334-14aa-2,SNHG14-335-14aa-2,SNHG14-338-14aa-1,SNHG14-340-14aa-1,SNHG14-342-14aa)
Grand Average of Hydropathicity 0.3786
Relative Molecular Mass 2011.34
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000669814;SNHG14-325
Transcript Length 6429
Coding Ability 0.4117
DNA Sequence Corresponding to Peptide ATGATTTTTTTTCAAAAATTCAAAGCATATTTAAATAATATA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :